Sterling Capital Management’s Immix Biopharma IMMX Stock Holding History

Sterling Capital Management’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49K	Buy	+144	New	+$1.34K	﹤0.01%	3059

Other funds holding IMMX

Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Commonwealth Equity Services

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Sterling Capital Management's IMMX Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Immix Biopharma (IMMX) in Q2 2026: 144 shares worth $1.49K. The stake represents ﹤0.01% of the portfolio and ranks #3059 among its holdings.

12 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

Sterling Capital Management held 144 shares of Immix Biopharma worth $1.49K as of Q2 2026.
Immix Biopharma was a new Sterling Capital Management position in Q2 2026.
Immix Biopharma made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3059 holding.
12 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.